Tailored eculizumab regimen for patients with atypical hemolytic uremic syndrome: requirement for comprehensive complement analysis
- PMID: 24942998
- DOI: 10.1111/jth.12639
Tailored eculizumab regimen for patients with atypical hemolytic uremic syndrome: requirement for comprehensive complement analysis
Comment on
-
Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome.J Thromb Haemost. 2014 Sep;12(9):1440-8. doi: 10.1111/jth.12615. Epub 2014 Jul 16. J Thromb Haemost. 2014. PMID: 24853860
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
